
Lassa Fever Vaccine Study Enrollment Begins
NIH announced today that enrollment has begun for participants in a Lassa fever vaccine study at the University of Maryland School of Medicine, which the federal agency is sponsoring. The trial will enroll up to 55 healthy adults between the ages of 18 and …